Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Papaverine therapy in atopic dermatitis.

R L Baer

    Journal of the American Academy of Dermatology
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Oral papaverine hydrochloride effectively reduces itching in atopic dermatitis patients. This treatment is not beneficial for other itchy skin conditions and should complement other therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mechanism of in vitro photohemiolysis in erythropoietic protoporphyria (EPP).

    The Journal of investigative dermatology·2015
    Same author

    Clinical uses of 2,3-dimercaptopropanol (BAL); studies on the toxicity of BAL on percutaneous and parenteral administration.

    The Journal of clinical investigation·2010
    Same author

    Clinical uses of 2,3-dimercaptopropanol (BAL); skin sensitization to BAL.

    The Journal of clinical investigation·2010
    Same author

    Studies in hypersensitivity to light; a preliminary report.

    The Journal of investigative dermatology·2010
    Same author

    Effect of pyribenzamine on dermographism (urticaria factitia).

    The Journal of investigative dermatology·2010
    Same author

    Methods for the rapid evaluation of the beneficial and harmful effects of agents applied to the human skin.

    The Journal of investigative dermatology·2010

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Atopic dermatitis is a chronic inflammatory skin condition characterized by intense itching.
    • Current treatments aim to manage symptoms and prevent skin damage.

    Purpose of the Study:

    • To evaluate the efficacy of oral papaverine hydrochloride in alleviating pruritus associated with atopic dermatitis.
    • To determine if papaverine hydrochloride is effective for other pruritic dermatoses.

    Main Methods:

    • Patients with atopic dermatitis received oral papaverine hydrochloride (100 mg multiple times daily or 150 mg timed-release capsules).
    • The study assessed the reduction in itching as a primary outcome.
    • Effectiveness in other itchy dermatoses was also investigated.

    Main Results:

    Related Experiment Videos

    • Oral papaverine hydrochloride significantly decreased itching in patients with atopic dermatitis.
    • The medication did not demonstrate beneficial effects in other itchy dermatoses.
    • Itching reduction was observed with both immediate-release and timed-release formulations.

    Conclusions:

    • Papaverine hydrochloride is a potentially effective adjuvant therapy for managing pruritus in atopic dermatitis.
    • It should be used alongside established treatments for atopic dermatitis.
    • Oral papaverine hydrochloride is not indicated for other pruritic skin conditions.